Escitalopram Oxalate
- Product NDC
- 16571-769
- 11-digit product format
- 165710769
- Labeler code
- 16571
- Product ID
- 16571-769_abf4fee5-eae0-4b5c-8b7d-7d055d36e530
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Escitalopram Oxalate
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Rising Pharma Holdings, Inc.
- Application
- ANDA079062
- Marketing category
- ANDA
- Marketing start
- 2012-04-03
- Substance
- ESCITALOPRAM OXALATE
- Active strength
- 5 mg/5mL
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Escitalopram Oxalate
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ESCITALOPRAM OXALATE | 5 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5U85DBW7LO |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 16571-769-24 | Escitalopram Oxalate | 240 mL in 1 BOTTLE | SOLUTION | 240 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 16571-769 | ESCITALOPRAM OXALATE SOLUTION [RISING PHARMA HOLDINGS, INC.] | 9 | Current NDC, Legacy NDC, 1 package rows | 20240612_79fddc2d-2dc2-444f-8fd3-0337090ee744.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16571-769-24 | 16571076924 | 240 mL in 1 BOTTLE (16571-769-24) | 240 ml | 2012-04-03 | 0000-00-00 | No | No | Current |